Professor, Pediatrics, USC School of Medicine
Pediatric Hematology & Oncology
Dr. Paul S. Gaynon, MD
|
|
Give Review
Paul S. Gaynon is an expert in the field of Pediatric Hematology & Oncology. He went to University of Illinois College of Medicine. He received 1 awards: "Super Doctor". Dr. Paul S. Gaynon is a published MD as well. He has 49 publications published. The latest was: Outcome of Children with Standard-Risk T-Lineage Acute Lymphoblastic Leukemia-Comparison among Different Treatment Strategies.
Publications
- End of induction minimal residual disease alone is not a useful determinant for risk stratified therapy in pediatric T-cell Acute lymphoblastic leukemia.
- Outcome of Children with Standard-Risk T-Lineage Acute Lymphoblastic Leukemia-Comparison among Different Treatment Strategies.
- Improving access to novel agents for childhood Leukemia.
- Increased post-induction intensification improves outcome in children and adolescents with a markedly elevated white blood cell count (≥200 × 10(9) /l) with T cell acu...
- CD19-antigen specific nanoscale liposomal formulation of a SYK P-site inhibitor causes apoptotic destruction of human B-precursor Leukemia cells.
- Impact on Survival and Toxicity by Duration of Weight Extremes During Treatment for Pediatric Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group.
- Philadelphia chromosome-negative very high-risk Acute lymphoblastic leukemia in children and adolescents: results from Children's Oncology Group Study AALL0031.
- Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive Acute lymphoblastic leukemia: Children's Oncology Group Study AALL0031.
- A Phase I Study of EZN-3042, a Novel Survivin Messenger Ribonucleic Acid (mRNA) Antagonist, Administered in Combination With Chemotherapy in Children With Relapsed Acu...
- Nanoscale liposomal formulation of a SYK P-site inhibitor against B-precursor Leukemia.
- Subcutaneous Panniculitis-Like T-Cell Lymphoma in Two Pediatric Patients: An HIV-Positive Adolescent and a 4-Month-Old Infant.
- Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with Acute lymphoblastic leukaemia: results fro...
- ABT-751 in Relapsed Childhood Acute Lymphoblastic Leukemia.
- Anaphylactic reaction to etoposide phosphate.
- Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed Acute lymphoblastic leukemia.
- A remembrance: James B. Nachman 1948-2011.
- James B. Nachman, 1948 to 2011: a remembrance.
- Escalating intravenous methotrexate improves event-free survival in children with standard-risk Acute lymphoblastic leukemia: a report from the Children's Oncology Group.
- Postrelapse survival in childhood Acute lymphoblastic leukemia is independent of initial treatment intensity: a report from the Children's Oncology Group.
- Outcome for children treated for relapsed or refractory Acute myelogenous leukemia (rAML): a Therapeutic Advances in Childhood Leukemia (TACL) Consortium study.
- Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk Acute lymphoblastic leukemia: report of the Children's Oncolo...
- Outcome of patients treated for relapsed or refractory Acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium study.
- Prospective monitoring for invasive aspergillosis using galactomannan and polymerase chain reaction in high risk pediatric patients.
- Improved early event-free survival with imatinib in Philadelphia chromosome-positive Acute lymphoblastic leukemia: a children's oncology group study.
- Young adults with Acute lymphoblastic leukemia have an excellent outcome with chemotherapy alone and benefit from intensive postinduction treatment: a report from the ...
- Factors influencing survival after relapse from Acute lymphoblastic leukemia: a Children's Oncology Group study.
- Reinduction platform for children with first marrow relapse of Acute lymphoblastic Leukemia: A Children's Oncology Group Study[corrected].
- Early postinduction intensification therapy improves survival for children and adolescents with high-risk Acute lymphoblastic leukemia: a report from the Children's On...
- Specific extra chromosomes occur in a modal number dependent pattern in pediatric Acute lymphoblastic leukemia.
- Treatment of pediatric Acute lymphoblastic leukemia: progress achieved and challenges remaining.
- Obesity and outcome in pediatric Acute lymphoblastic leukemia.
- Risk- and response-based classification of childhood B-precursor Acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Gr...
- Asparagine depletion after pegylated E. coli asparaginase treatment and induction outcome in children with Acute lymphoblastic leukemia in first bone marrow relapse: a...
- Bone marrow transplantation versus prolonged intensive chemotherapy for children with Acute lymphoblastic leukemia and an initial bone marrow relapse within 12 months ...
- Phase II study of clofarabine in pediatric patients with refractory or relapsed Acute lymphoblastic leukemia.
- Treatment adherence and 6-mercaptopurine metabolites.
- Lymphoblast biology and outcome among children with Down syndrome and ALL treated on CCG-1952.
- Preponderant mitotic activity of nonleukemic cells plays an important role in failures to detect abnormal clone in childhood Acute lymphoblastic leukemia.
- Racial and ethnic differences in survival of children with Acute lymphoblastic leukemia.
- Response to Donadieu and Hill "Clinical trials in childhood Acute lymphoblastic leukemia: a common prognostic classification and a common induction therapy are no...
- Glutathione S-transferase genotypes, genetic susceptibility, and outcome of therapy in childhood Acute lymphoblastic leukemia.
- Low incidence of second neoplasms among children diagnosed with Acute lymphoblastic leukemia after 1983.
- A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard...
- From where do clinical trials come?
- A pharmacoeconomic analysis of pegaspargase versus native Escherichia coli L-asparaginase for the treatment of children with standard-risk, Acute lymphoblastic leukemi...
- Abnormalities of chromosome bands 15q13-15 in childhood Acute lymphoblastic leukemia.
- High-resolution melting curve analysis, a rapid and affordable method for mutation analysis in childhood Acute myeloid leukemia.
- Constitutive Function of the Ikaros Transcription Factor in Primary Leukemia Cells from Pediatric Newly Diagnosed High-Risk and Relapsed B-precursor ALL Patients.
Schools
University Of Illinois College Of Medicine Chicago
Stanford University Hospital
Children39s Memorial Hospital
Conditions Treated
- Acute Leukemia
- Anemia
- Coagulation Disorders (incl. Hemophilia)
- Deep Vein Thrombosis (DVT)
- View All
Doctors Specialties
- Pediatric Hematology
- Oncology
Accepted Insurances
Awards
- Super Doctor
Education
-
Stanford University -
University of Illinois College of Medicine
Hospital
-
Children's Hospital Los Angeles
Helpful Reviews
Similar Doctors
|
|
Dr. Roy L. Kao, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shira T. Rosenberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Diane Nugent, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. David M. Tishler, MD
This Doctor is OpenDoctor Recommended.
|